• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰荨麻疹的流行病学——全国代表性调查结果

Epidemiology of urticaria in Poland - nationally representative survey results.

作者信息

Raciborski Filip, Kłak Anna, Czarnecka-Operacz Magdalena, Jenerowicz Dorota, Sybilski Adam, Kuna Piotr, Samoliński Bolesław, Wg Eup

机构信息

Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.

Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Postepy Dermatol Alergol. 2018 Feb;35(1):67-73. doi: 10.5114/ada.2018.73165. Epub 2018 Feb 20.

DOI:10.5114/ada.2018.73165
PMID:29599674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5872247/
Abstract

INTRODUCTION

The prevalence of urticaria is 15-20%. Women are twice as likely to be affected.

AIM

To present the epidemiology of urticaria and angioedema in Poland.

MATERIAL AND METHODS

A questionnaire-based survey was conducted on a representative group of 4,897 individuals, aged 15-74 years.

RESULTS

A total of 11.2% of respondents reported at least one episode of urticaria symptoms in their life, and the frequency was higher in females (OR = 1.46; < 0.001). Single episodes accounted for 34.8%, while repeated episodes accounted for 65.2%. Acute urticaria was observed in 10.6% (more frequent in females; OR = 1.41; < 0.001), chronic in 0.6%. Median age of the first episode was 15 years. Angioedema was observed in 3.2%. The last episode of urticaria symptoms and/or angioedema occurred within the previous week in 0.7% of subjects, the last month in 1%, and the last year in 2.2%. 8.8% had experienced urticaria symptoms or angioedema over 1 year prior to the survey. The impact of urticaria symptoms on patients' daily activities was rated with 3.8 points on a scale of 0-10. In addition, chronic urticaria was rated 6.5, and acute urticaria 3.6. Angioedema and urticaria had a negative impact of 5.7 points.

CONCLUSIONS

Urticaria and angioedema are serious health problems in Poland, although their prevalence is below the mean rate for the global population. Females are more likely to suffer from these diseases. People affected by urticaria most frequently report contact with plants and substances, insect bites/stings, and food as the provoking factors.

摘要

引言

荨麻疹的患病率为15% - 20%。女性受影响的可能性是男性的两倍。

目的

介绍波兰荨麻疹和血管性水肿的流行病学情况。

材料与方法

对4897名年龄在15 - 74岁的具有代表性的人群进行了问卷调查。

结果

共有11.2%的受访者报告一生中至少有一次荨麻疹症状发作,女性的发作频率更高(比值比=1.46;P<0.001)。单次发作占34.8%,而反复发作为65.2%。观察到急性荨麻疹的发生率为10.6%(女性更常见;比值比=1.41;P<0.001),慢性荨麻疹为0.6%。首次发作的中位年龄为15岁。血管性水肿的发生率为3.2%。0.7%的受试者在过去一周内出现过荨麻疹症状和/或血管性水肿的最后一次发作,1%在过去一个月内,2.2%在过去一年内。8.8%的人在调查前一年多曾经历过荨麻疹症状或血管性水肿。荨麻疹症状对患者日常活动的影响在0 - 10分的量表上评分为3.8分。此外,慢性荨麻疹评分为6.5分,急性荨麻疹为3.6分。血管性水肿和荨麻疹的负面影响评分为5.7分。

结论

在波兰,荨麻疹和血管性水肿是严重的健康问题,尽管其患病率低于全球人口的平均水平。女性更容易患这些疾病。受荨麻疹影响的人最常报告接触植物和物质、昆虫叮咬/蜇伤以及食物为诱发因素。

相似文献

1
Epidemiology of urticaria in Poland - nationally representative survey results.波兰荨麻疹的流行病学——全国代表性调查结果
Postepy Dermatol Alergol. 2018 Feb;35(1):67-73. doi: 10.5114/ada.2018.73165. Epub 2018 Feb 20.
2
[Round Table: Urticaria and angioedema: introduction and classification].[圆桌会议:荨麻疹和血管性水肿:引言与分类]
Allergol Immunopathol (Madr). 1999 Mar-Apr;27(2):71-3.
3
Epidemiology of urticaria including physical urticaria and angioedema in Korea.韩国的荨麻疹(包括物理性荨麻疹和血管性水肿)流行病学。
Korean J Intern Med. 2019 Mar;34(2):418-425. doi: 10.3904/kjim.2017.203. Epub 2018 May 11.
4
[Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico].[墨西哥东北部城市地区慢性荨麻疹和血管性水肿的患病率及潜在触发因素]
Rev Alerg Mex. 2004 Sep-Oct;51(5):181-8.
5
Quality of life assessment in patients with chronic urticaria.慢性荨麻疹患者的生活质量评估
An Bras Dermatol. 2011 Sep-Oct;86(5):897-904. doi: 10.1590/s0365-05962011000500006.
6
Suspected tartrazine-induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge.疑似酒石黄诱发的急性荨麻疹/血管性水肿很少能通过口服激发试验再现。
Clin Exp Allergy. 2003 Dec;33(12):1725-9. doi: 10.1111/j.1365-2222.2003.01825.x.
7
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.奥马珠单抗对 H1 抗组胺药耐药性慢性自发性荨麻疹患者血管性水肿的影响:X-ACT 随机对照试验的结果。
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.
8
Patients with Chronic Urticaria Remain Largely Undertreated: Results from the DERMLINE Online Survey.慢性荨麻疹患者大多未得到充分治疗:DERMLINE在线调查结果
Dermatol Ther (Heidelb). 2021 Jun;11(3):1027-1039. doi: 10.1007/s13555-021-00537-5. Epub 2021 May 4.
9
Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria.白三烯受体拮抗剂可能预防非甾体抗炎药诱发的慢性荨麻疹患者病情加重。
Ann Allergy Asthma Immunol. 2000 Aug;85(2):156-7. doi: 10.1016/S1081-1206(10)62457-X.
10
[Prevalence of food allergy in patients with urticaria-angioedema syndrome].[荨麻疹-血管性水肿综合征患者食物过敏的患病率]
G Ital Dermatol Venereol. 1990 Aug;125(7-8):319-22.

引用本文的文献

1
Use of over-the-counter antiallergic products-analysis of sales data in Poland from 2020 to 2023.非处方抗过敏产品的使用——波兰2020年至2023年销售数据分析
Front Pharmacol. 2025 Aug 22;16:1649349. doi: 10.3389/fphar.2025.1649349. eCollection 2025.
2
Urticaria in China: incidence, prevalence, and disability-adjusted life years compared with G20 countries: findings from the Global Burden of Disease study 2021.中国的荨麻疹:与二十国集团国家相比的发病率、患病率及伤残调整生命年:全球疾病负担研究2021的结果
Arch Dermatol Res. 2025 Mar 12;317(1):548. doi: 10.1007/s00403-025-04051-y.
3
Investigating the association of atopy and aeroallergen sensitization and chronic spontaneous urticaria.

本文引用的文献

1
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.变应性接触性皮炎诊断和治疗的欧洲指南(2013 年版)
Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30.
2
Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.荨麻疹控制测试的制定与验证:一种用于评估荨麻疹控制状况的患者报告结局测评工具。
J Allergy Clin Immunol. 2014 May;133(5):1365-72, 1372.e1-6. doi: 10.1016/j.jaci.2013.12.1076. Epub 2014 Feb 9.
3
Prevalence of skin diseases in a dermatology outpatient clinic in Turkey. A cross-sectional, retrospective study.
研究特应性、吸入性变应原致敏与慢性自发性荨麻疹之间的关联。
Postepy Dermatol Alergol. 2022 Feb;39(1):121-125. doi: 10.5114/ada.2022.113805. Epub 2022 Feb 28.
4
The efficacy and safety of herbal combination of Unani Medicine in chronic urticaria: A randomized, controlled study.尤纳尼医学草药组合治疗慢性荨麻疹的疗效与安全性:一项随机对照研究。
J Tradit Complement Med. 2021 Jan 4;11(4):303-310. doi: 10.1016/j.jtcme.2020.12.003. eCollection 2021 Jul.
5
Risk Factors for Acute Urticaria in Central California.加利福尼亚中部急性荨麻疹的危险因素。
Int J Environ Res Public Health. 2021 Apr 2;18(7):3728. doi: 10.3390/ijerph18073728.
6
Prevalence and potential risk factors of urticaria in the Polish population of children and adolescents.波兰儿童及青少年群体中荨麻疹的患病率及潜在风险因素
Postepy Dermatol Alergol. 2020 Oct;37(5):785-789. doi: 10.5114/ada.2020.100489. Epub 2020 Nov 7.
7
Investigation of self-reported chronic urticaria among adults in grasslands of northern China.中国北方草原地区成年人自我报告的慢性荨麻疹调查。
Medicine (Baltimore). 2020 Nov 20;99(47):e23301. doi: 10.1097/MD.0000000000023301.
8
Primary Non-Adherence to Antihistamines-Conclusions From E-Prescription Pilot Data in Poland.波兰电子处方试点数据得出的关于抗组胺药的原发性不依从性结论
Front Pharmacol. 2020 May 21;11:783. doi: 10.3389/fphar.2020.00783. eCollection 2020.
9
The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria - a pilot study.左西替利嗪和孟鲁司特对慢性自身免疫性荨麻疹患者临床症状、血清水平及COX-1和COX-2酶皮肤表达的影响——一项初步研究
Postepy Dermatol Alergol. 2020 Feb;37(1):73-80. doi: 10.5114/ada.2018.79731. Epub 2018 Nov 23.
土耳其一家皮肤科门诊诊所皮肤病的患病率。一项横断面回顾性研究。
J Dermatol Case Rep. 2013 Dec 30;7(4):108-12. doi: 10.3315/jdcr.2013.1156. eCollection 2013.
4
Occupational dermatoses by type of work in Greece.希腊各类工作中的职业性皮肤病。
Saf Health Work. 2013 Sep;4(3):142-8. doi: 10.1016/j.shaw.2013.06.001. Epub 2013 Jul 20.
5
Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: a population-based cross-sectional survey.成人自报的特应性皮炎终身患病率及与哮喘和湿疹的合并症:基于人群的横断面调查。
Acta Derm Venereol. 2013 Jul 6;93(4):438-41. doi: 10.2340/00015555-1522.
6
Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients.药物过敏反应:大型系列患者中的反应模式、涉及药物和时间变化。
J Investig Allergol Clin Immunol. 2012;22(5):363-71.
7
Epidemiology of non-hereditary angioedema.非遗传性血管性水肿的流行病学。
Acta Derm Venereol. 2012 Sep;92(5):475-9. doi: 10.2340/00015555-1389.
8
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.慢性自发性荨麻疹未满足的临床需求。GA²LEN 工作组报告。
Allergy. 2011 Mar;66(3):317-30. doi: 10.1111/j.1398-9995.2010.02496.x. Epub 2010 Nov 17.
9
Can Internet surveys help us understanding allergic disorders? - results from a large survey in urticaria in Greece.互联网调查能否帮助我们了解过敏疾病?——一项希腊荨麻疹大型调查的结果。
J Eur Acad Dermatol Venereol. 2011 May;25(5):532-7. doi: 10.1111/j.1468-3083.2010.03817.x. Epub 2010 Aug 12.
10
Epidemiology of urticaria: a representative cross-sectional population survey.荨麻疹的流行病学:一项具有代表性的横断面人群调查。
Clin Exp Dermatol. 2010 Dec;35(8):869-73. doi: 10.1111/j.1365-2230.2010.03840.x.